EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Suspected Delayed Oxaliplatin-Associated Sinusoidal Obstruction Syndrome in a Patient with Non-metastatic Stage IIC Colorectal Adenocarcinoma: A Case Report

Basil Jalamneh, Anas Odeh, Moath Al Bliwi, Islam B. Mohamed, Lana Dardari, Noma Dakhil, Mohiuddin Syed, Hamed Daw

Case Reports in Oncology · 2026-11-10

DOI: 10.1159/cro/abzag100 ↗
AbstractBibliografische Angaben

Abstract

Abstract Introduction: Oxaliplatin-associated sinusoidal obstruction syndrome (SOS) is well recognized in patients receiving chemotherapy for colorectal liver metastases, particularly in hepatectomy specimens, but clinically manifest disease after adjuvant therapy for nonmetastatic colorectal cancer is rarely reported. We describe suspected delayed SOS identified during routine surveillance after curative-intent treatment. Case Presentation: A 42-year-old woman with stage IIC (T4bN0M0), microsatellite-stable sigmoid adenocarcinoma underwent curative resection followed by 12 cycles of adjuvant fluorouracil, leucovorin, and oxaliplatin. Oxaliplatin was dose-reduced for neuropathy. Surveillance computed tomography 1 month after treatment showed borderline splenomegaly. Thirteen months after chemotherapy, recognition of a recanalized left umbilical vein prompted hepatology evaluation. Magnetic resonance imaging confirmed the collateral without cirrhosis or steatosis, and endoscopy demonstrated no varices. Endoscopic ultrasound-guided direct measurements yielded mean portal and hepatic vein pressures of 12 and 14 mmHg, respectively, giving a gradient of −2 mmHg. Liver biopsy demonstrated centrilobular congestion, hepatocellular collapse, and prominent portal veins without significant fibrosis or central venular obliteration. These findings supported vascular liver injury, with oxaliplatin-associated SOS considered a presumptive diagnosis. Multidisciplinary expectant surveillance was pursued. Conclusion: Oxaliplatin-associated vascular liver injury may be recognized more than a year after adjuvant therapy in patients without liver metastases. Splenomegaly, platelet changes, unexplained liver enzyme abnormalities, or portosystemic collaterals on routine surveillance should prompt further evaluation. Nonspecific biopsy findings and discordant pressure measurements require cautious diagnostic interpretation.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →